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Background:  The  number  of chemicals  in household  products  has  driven  concern  about  potential  adverse
health  through  their  use.  Most  research  concentrates  on  product  chemicals  with  reproductive  and  car-
cinogenic  consequences,  however  some  evidence  exists  that  immune  effects  can  lead  to exacerbation  of
autoimmune  illnesses  such  as  lupus  (SLE).
Objectives:  This  paper examines  household  and  personal  product  exposure  patterns  in a pilot  case/control
study  of  female  Australians.  We  also examined  associations  between  common  product  exposure  and  SLE
symptom exacerbation  over  a year  period.
Methods:  We  enrolled  41  control  and  80 SLE  participants  aged  18–80  years.  Qualitative  techniques  of
structured  interview  and  thematic  analysis  retrospectively  explored  patterns  of product  use, and  ﬂare
history  data  of  SLE  participants.  Negative  binomial  regression  models  explored  associations  between
self-reported  ﬂare  (SRF)  days  and  exposure  to 34  common  home  product  groups.
Results: Mean  product  counts  did  not  differ  between  participant  groups  (mean  33.1: SD 11.8),  or  ﬂare
groups  (ﬂare mean  32.6:SD  12,  no-ﬂare  31.8:SD  6.6). Products  used  for personal  hygiene  and  general
house  cleaning  were  most  frequently  used.Signiﬁcant  association  with  increased  SRF  day  relative  risk
(IRR)  was  seen  for  bath  oil use  (IRR  1.008,  CI 1.00–1.02).  Paradoxical  “protective”  effects,  (reduced  SRF
days)  were found  for cleansing  beauty  (IRR 0.999,  CI  0.998–0.999),  make-up  (IRR  0.998, CI  0.997–0.999);
adhesives  (IRR  0.994,  CI 0.991–0.997)  and  paint  (IRR  0.99,  CI 0.986–0.995).
Conclusions:  Everyday  product  exposures  can  impact  on symptom  exacerbation  in  SLE.  Some  offering
protection  and  others  increased  health  risk.  Identifying  environmental  associations  offer  the possibility
of  life-style  interventions  to  reduce  illness  impact.
Crown  Copyright  © 2015  Published  by  Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under  the  CC. Introduction
The large number of new chemicals available in commercial and
ousehold products on the worldwide market has driven concern
bout potential adverse health impacts from these components
1,2]. Most research to date has concentrated on animal models
nd on agents with potential for endocrine disruption, in particular
hose chemicals with reproductive and carcinogenic consequences,
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ax:  +61 249855347.
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214-7500/Crown Copyright © 2015 Published by Elsevier Ireland Ltd. This is an open ac
y-nc-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
but many information gaps still exist,particularly in regards to
immune- endocrine and neuro-endocrine systems.
Our lack of understanding regarding the impact of everyday
exposures as well as the cumulative impact of exposure interac-
tions presents a signiﬁcant challenge in the assessment of health
risk. Studies investigating the pathogenic potential of common
environmental and chemical agents are limited, with most toxico-
logical studies concentrating on single chemical components rather
than end product mixtures [3]. The enclosed nature of modern
indoor environments, (including homes, workplaces, activity cen-
ters, and also transport modes), and the time spent within these
environments, increases an individual’s potential for environmen-
tal exposure. Estimates of time spent indoors within developed
communities range from 85% to 95% [4]. This also increases the
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Table 1
Household cleaning and personal product groups.
Product groups
Adhesives Fertilizers
Air fresheners/deodorisers Solid fuels
Cleaners general Fixatives
Bleach Herbicides, insecticides, pesticides
Cleaners – furniture, homewares Laundry cleaners
Protector waxes/polish Make-up
Cleaners carpet Paint
Cleansing beauty Cleaning acids
Ammonia Powder beauty
Degreasers Solvents
Deodorant Bath oil
Hair removers Powdered salt
Dishwasher Hydrocarbons
Disinfectants/antiseptics Beauty colorantsM.L. Squance et al. / Toxico
otential for chemicals to accumulate in tissues and organs creating
 cumulative burden.
Impacts on health associated with exposure to a wide number
f environmental agents have been reported, including immune
ffects leading to auto immune illnesses [3]. In addition, a collabo-
ative investigation into autoimmunity and exposure to chemicals,
y an international panel of experts, as part of the Interorganiza-
ion Programme for the Sound Management of Chemicals (IPSMC),
uggested that environmental exposures can also exacerbate pre-
xisting autoimmune illnesses [3].
SLE is characterized by multi-system involvement that can be
ild through to life threatening and commonly exhibits periods of
ymptom quiescence and exacerbation (ﬂare events). Environmen-
al interactions along with intrinsic factors of genetics, hormones,
nd age play a role in the pathogenesis of the disease [5]. This
nterplay of endogenous and exogenous factors is thought to mod-
late endocrine and immune regulatory systems and to manifest
n either suppression or heightening of immune system responses
3]. Stimuli such as UV sunlight, certain pharmaceutical com-
ounds, hormones, infection and stress are the most researched and
ccepted symptom exacerbation effectors [5–7], however, in the
ast majority of individuals the reasons for ﬂares remains unclear.
Therefore, this paper will ﬁrst explore and compare patterns
f exposure to common household and personal products in a
ase/control study of female Australians, and will further examine
roduct exposure in the SLE patient group in relation to frequency
f self-reported symptom exacerbation “ﬂare” events (SRF) over
 one year period. The results of this pilot study will add to the
imited knowledge available regarding common everyday products
nd the contribution these products may  make to SLE symptom
xacerbation.
. Materials and methods
Validated qualitative research techniques using structured
nterview and thematic analysis [8] were used to explore data of
veryday product use and also the ﬂare history of SLE participants.
ata was of a self-reported nature representing events over the pre-
eding 12 month period. Institutional review and approval of study
rotocols and methods according to the Declaration of Helsinki
008 revision [9] was undertaken and received.
.1. Participants
Case (SLE) and control participants from Hunter/Central Coast
egions of New South Wales, Australia were recruited for a study
xamining environmental determinants of lupus ﬂares (EDOLF).
ritten study consent for participation in the study was  received
rom all participants. The study cohort contains a mix  of 41 con-
rol participants and also 80 SLE participants with a health audit
onﬁrmed diagnosis according to the American College of Rheuma-
ology (ACR) Classiﬁcation guidelines for SLE [10]. Participants were
ged between 18 and 80 years and were all female. Participant
ecruitment and health audit methods have been previously out-
ined in detail [11].
.2. Data collection
Participants were posted study speciﬁc questionnaires for com-
letion prior to attending scheduled study appointments where
uestionnaires were collected and checked for completion. A
rimary study questionnaire captured participant demographic,
ifestyle and relevant medical history including routine health man-
gement practices, use of medicines, sun protection products, and
omplementary medicines or therapies. Measurements of bodyCaustic cleaners Perfumes
Dry cleaning Flame retardants
Equipment oils & petrol Fluoride (potable public water)
mass index (BMI) were also taken and calculated according to Aus-
tralian Government Health guideline categories [12]. A 0–100 point
visual analogue scale (VAS) with end points of “not stressed at
all” and “highly stressed” were used to record current stress lev-
els. Additional study questions captured data related to previously
reported SLE ﬂare risk factors, in particular:
1. Home environment characteristics including location of garages,
recent renovation and fumigation activities, and use of either
public or private water supply;
2. lifestyle practices including indoors and outdoor activity types
and times, hobbies and exercise regimes; and
3. personal hygiene and beauty practices.
Participants also completed a Home Cleaning and Maintenance
Product list (HCMPL) questionnaire which documented exposure
and use of commercial products for personal hygiene and house-
hold cleaning.
The HCPML was  to be completed in the month between receipt
and the scheduled study appointment. Instructions were given
to each participant to document all the products that are used
within their home for cleaning and for personal care. Instructions
clearly stated that products could be used by any member of the
household including cleaners and carers. To aid the participant in
the self-documentation task and to ensure a more comprehensive
list of products, a prompt guide of 5 house areas (kitchen, bath-
room/toilet, laundry, garage, garden shed) was included; however
participants were not limited to these areas. The HCPML asked for
descriptions and brand names of products recorded as well as how
often the product was  used over the past year (“daily”, “weekly”,
“monthly”, “yearly” or “do not know”). The HCPML template is
included as supplementary material.
2.2.1. Product exposure assessment
HCPML reported products were coded into 96 product subtypes
and aggregated based on product type and description of use into
the 34 product groups listed in Table 1. Home and personal product
exposure for each participant was calculated as a day count by the
collation of self-reported participant product activity information.
The total product exposure day counts (EDC) were calculated from
cumulative counts of each product’s days of use within the HCPML
with the addition of product group information contained within
the primary questionnaire. Speciﬁcally, groups included: lifestyle
and activity information; product group exposure due to hobbies;
renovation or home fumigation activities; and ﬂuoride exposure
through drinking and cooking water source. Reported product use
days were scored as ‘daily’ (365 days), ‘weekly’ (52), ‘monthly’
882 M.L. Squance et al. / Toxicology Reports 2 (2015) 880–888
Table 2
Characteristics of participant groups.
Characteristic Control
(N = 41)
SLE
(N = 80)
Difference between groups
Mean ± SD Mean ± SD p-Value
Age (years) 49.8 ± 12.4 47.7 ± 13.5 1.0
Diagnosis (years) 7.7 ± 6.2
Indoor hr portion 0.81 ± 0.1 0.84 ± 0.13 0.97
Body  Mass Index score 25.9 ± 4.8 27.4 ± 5.6 1.0
Stress  level (VAS) 25.4 ± 22 50.1 ± 27.4 1.0
Socio  Economic Status (SES) 1.2 ± 0.5 1.1 ± 0.55 0.1
SRF  days (year) 29.2 ± 8.9
SRF  number (year) 6.8 ± 2.1
n  (%) n (%) p-Value
Educational background 0.43
Socio  economic status 0.48
Above average 10(24.4) 15(18.8)
Average 29(70.7) 56(70.0)
Below  average 2(4.9) 9(11.3)
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Regular sun 28(68.3) 
Use  sunscreen 32(78) 
12), ‘yearly’ (1), ‘when necessary’ or ‘as needed’ (1), ‘rarely’ (1),
never’ (0). In addition, if a participant speciﬁed a day number for
 product group use this number was used within the calculation.
rosschecking of product groups listed in HCPML and question-
aire information occurred to ensure duplicate counts were not
ecorded and calculated within total EDC. Allocation of EDC for
eported activities were based on available literature and personal
ommunications with expert practitioner hobby groups for com-
on  exposures. Published out gassing estimates were also used
hen available for activities such as fumigation, renovation or
ew carpeting/furnishing as well as some hobbies involving sol-
ents/adhesives, if not available then an estimate of 6 weeks or 42
DC’s were used. Reported activity with associated product group
nd exposure EDC score allocation details are provided as a sup-
lement to this paper. Calculated product EDC were standardized
cross the cohort by portioning the total day count in relation to
ndividual participant nominated hours spent within an indoors
nvironment within averaged weekday and weekend day hours.
.2.2. Self-reported ﬂare (SRF) assessment
SLE participants took part in a structured interview to record
heir personal perspectives and accounts of SRF activity over the 12
onths prior to interview. To limit self-report error, a participant
are deﬁnition describing an autoimmune illness with symptom
uctuations was chosen and used in the interview.
An exacerbation is deﬁned as: The appearance of a new clin-
ical sign/symptom or the clinical worsening of a previous
sign/symptom that had been stable for at least the previous 30
days and which persisted for a minimum of 24 h [13].
Participant reported ﬂare counts and average length of ﬂare
vents were used to establish a total count of SRF days for the study
ear. Detailed information of structured interview is speciﬁcally
utlined in previously published material [14].
.3. Statistics
Simple descriptive statistics summarize participant group
emographic information. Association tests between participant
roups were performed on product EDC via one-way Anova for con-
inuous variables, and also Fisher’s exact test of independence for
ichotomous variables.
Regression models explored the association between self-
eported ﬂare events and exposure to the 34 home product groups.6(7.5) 0.42
39(48.8) 0.05
65(81.3) 0.81
General linear modeling based upon a negative binomial robust
link function using dichotomous and continuous count data was
used due to over dispersion of the dependent SRF variable. Initial
models included all variables of interest with a backward stepwise
approach adopted for covariates of age; diagnosis years; educa-
tional level; socio economic status (SES); body mass index (BMI)
and use of vitamin D supplementation, hormones and immune
therapy medications (ITM). Signiﬁcant p values (<0.05) were noted
for diagnosis years and ITM use, so they were retained in multi-
variate models with associations expressed as incidence rate ratios
(IRR) with 95% conﬁdence intervals.
Following principles adopted in exposure assessment, prod-
uct EDC and SRF data were further explored by dichotomising
participant exposure/non-exposure based on exposure prevalence
cut-points. This approach is used when exposure monitoring data is
absent or insufﬁcient due to variability in exposure patterns across
differing environments, time periods and work practices [15–19].
All analysis was  performed using STATA v11.0 (StataCorp LP,
College Station, Texas, USA).
3. Results
An audit of 159 patient health records was  undertaken with 83
including documentary evidence of 4 or more SLE criteria according
to the ACR classiﬁcation guidelines. Three of these SLE participants
self-reported “constant” ﬂaring during interview and were not con-
sidered to be representative of a relapsing and remitting ﬂare state,
therefore their data were not included in the ﬁnal analysis. Forty
one control participants completed all comparison study compo-
nents. Demographic data of relevance for both groups are shown in
Table 2 along with analysis of difference between groups. Mean age
of participants was 48 years for SLE participants and 50 for control
participants. Length of time post SLE diagnosis averaged 7.7 years
(SD 6.2). The study participants were all female and primarily Cau-
casian (97.5%) with similar levels of BMI, education and SES with 91
% reporting SES of either “above Australian average” or “Australian
average”. The proportion of current smokers did not signiﬁcantly
differ (control 2.4%: SLE 7.5%).
Ultraviolet light (UV) exposure can lead to photosensitive
responses as well as potentially triggering ﬂare events. Therefore
details of time spent in the sun with and without sunscreen were
considered to be relevant. Regular time out in the sun differed
between SLE and control groups, but was  of borderline signiﬁcance
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p = 0.05);the reported use of sunscreen did not differ,reﬂecting
eneral adherence to sun protective measures.
Patterns of usage: participant groups.
Characteristics of exposure and product counts for each par-
icipant group were collated from questionnaires. One-way Anova
nalysis results showed similarity between participant groups in
espect to product use patterns of either exposure days or product
ounts. Total participant product counts ranged from a minimum of
3 products to a maximum of 81 different products used within the
ggregated 34 product groups. Mean number of total products for
he cohort was 33.1 with a standard deviation of 11.8. No signiﬁcant
ifferences between the groups were found for either total overall
roduct counts or for the majority of different product groups. Sig-
iﬁcant differences were found for the number of carpet cleaners
p = 0.03) and dish washing products (p = 0.01) used with control
articipants reporting high use.
Along with EDC and product counts, similarities were found for
he top 10 most frequently used product groups in each participant
roup. Some differences were evident in the overall order (Fig. 1);
owever, it was found that personal hygiene and household clean-
ng products were the most frequently used along with ﬂuoride,
ue to a ﬂuoridated potable public water supply. All but one par-
icipant reported use of tap water on a daily basis.However, a high
ercentage of both participant groups (control 14:34%, SLE 31:39%)
eported limiting public water use for personal washing and laun-
ry purposes only, and drinking and cooking water being drawn
rom either a ﬁltered or bottled water supply.
Patterns of usage: SLE participant ﬂare groups.
SLE participant product group exposure sub analysis based on
RF status was undertaken. Means, standard deviations (SD) and p
alue differences for the most frequently used product groups and
igniﬁcant product groups are presented in Table 3. In summary,
LE participants reporting SRF events were found to use between
3 and 81 total products with non-ﬂaring SLE participants report-
ng use of between 23 and 43 different products. Whilst count
anges did appear to indicate that ﬂaring SLE participants used
ore products, Anova analysis showed that mean product counts
id not differ between ﬂare groups(ﬂare mean 32.6:SD 12, no-ﬂare
1.8:SD 6.6). Signiﬁcant difference between the ﬂare groups was
nly found for the use of beauty colorants (hair dye: p = 0.02) and
owdered salts (p = 0.03); this could potentially be a false signal due
o the number of comparisons being made or an indication that SLE
atients avoided these exposures. Reported hair dye use either in
he home or in a salon was higher in SLE participants that did not
eport any ﬂares (mean 1.0:SD 0.4). The product group “powdered
alts” included commercial products used with the care of swim-
ing pools, cleaning salts of soda ash, bicarbonate of soda, and
ugar soap (CaCO3), moisture absorbers, and therapeutic salts used
or bathing and relaxation.
The most frequently used product groups were general cleaning,
leansing beauty inclusive of shampoos and wash gels, bleach, laun-
ry, deodorant and make-up. It should be noted that the product
roup of make-up included both foundation make-up and sun-
creen products only as other make-up of lipsticks, blushes or
ye-shadows were not recorded by any participants.
Product groups displayed within Table 3 represent products
ound to have the highest exposure for the study year with the addi-
ion of product groups which indicate a difference in use between
he control and SLE participant groups.
.1. Associations between product exposure and SRFNegative binomial regression was used to model SRF days (out-
ome) against independent EDC of all indoor hour adjusted product
roup variables with results summarized within Table 4. Covariate
actors of age, diagnosis years, education level, SES, BMI, smoking,eports 2 (2015) 880–888 883
stress, therapeutic supplements of vitamin D and ITM use in the
study year were tested for signiﬁcance with univariate modeling.
Signiﬁcant effects were found for diagnosis years (p = 0.028) and
ITM use (p = 0.009) which were retained in all subsequent multi-
variate models.
Signiﬁcant association consistent with increased SRF day risk
represented by relative risk (IRR) was seen for bath oil use only (IRR
1.008, CI1.00–1.02). Paradoxical “protective” effects, (reduced ﬂare
days) were found for cleansing beauty (IRR 0.999, CI0.998–0.999),
make-up use (IRR 0.998, CI0.997–0.999); adhesives (IRR 0.994, CI
0.991–0.997) and paint (IRR 0.99, CI 0.986–0.995).
The surprising risk reduction results for some product groups
were explored by plotting continuous group exposure data. These
plots displayed features suggestive of a non-linear non-monotonic
response as exempliﬁed by graphing SRF days against adhesive
exposure (Fig. 2). The ﬁgure represents an initial increase in SRF
days with low levels of adhesive product exposure days and
decreasing days with increasing exposure days. Alternatively, these
may  represent either false positives due to multiple comparisons
or avoidance of these products by those with more severe SLE.
Based on established assessment methods of semi-quantiﬁed
and quantiﬁed exposure estimates, robust negative binomial
regression models were repeated using dichotomised product
group data. As expert probability of exposure information was not
obtained for product groups, assignment of exposure and non-
exposure status was  based on: any reported use in the study year;
and also 5% and 10% cut-points of the maximum EDC score (max)
of each product group (max <5% (10%) non-exposed; max  ≥5%
(10%) exposed). Results for dichotomised data showed a signif-
icant relationship (p < 0.001) with increased SRF risk associated
with ﬂuoride exposure. Relative risk (IRR 2.7) was  maintained in
all models regardless of applied cut-points. Sixty one percent of
SLE participants reported not using ﬂuoridated water for drink-
ing and or cooking, limiting their exposure on a daily basis to skin
and aerosol routes. This reported practice was accommodated in
the data by scoring ﬂuoride exposure EDC at half a year score (183
EDC). Therefore, whilst this ﬁnding is of interest, the almost ubiqui-
tous use of ﬂuoridated water daily; along with the varying rates of
exposure based on purpose of use, warrants more speciﬁc prospec-
tive exposure measurement with reference to exposure routes and
levels.
Signiﬁcant results for regression modeling with 5% cut-point
product group exposures indicate an increased likelihood of SRF
days associated with exposure to general cleaners (IRR 3.61, CI
2.66–4.9), bleach and specialized cleaners of furniture and home
wares (IRR 2.97, CI 2.04–4.34), and solid fuels (IRR 2.97, CI 0.85–1.7).
Solid fuels were in the form of ﬁre and BBQ starter products infused
with ﬂammable liquid; however positive exposure was related
to only a few participants and should be interpreted with cau-
tion.Retention of signiﬁcance and a risk reduction of 2.97 were also
found for exposure to bleach at the 10% max cut-point.The 10%
max  cut-point also revealed signiﬁcant results for beauty colorants
(hair dye). Across the study year, hair dye was  used by 62 (77.5%)
of SLE participants and 50 (62.5%) participants reporting new event
exposures either monthly or more frequently. Unexpectedly, a 50%
reduction in risk was found with its use (IRR 0.51, CI 0.28–0.91).
4. Discussion
4.1. Exposure patterns of household and personal productsA major goal of this paper was to explore the types of prod-
ucts and patterns of exposure associated with routine household
and personal activities over a one year study period. The patterns
were examined across a small group of female Australians without
884 M.L. Squance et al. / Toxicology Reports 2 (2015) 880–888
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 medical history of SLE and also in a larger group with SLE. The
tudy then used exposure data to investigate associations between
roduct group exposure and SRF in the SLE patient group. This was
one to better inform our knowledge of ﬂare triggers and products
f concern that could potentially trigger ﬂare events in SLE.
The process was resource-intensive but did provide useful infor-
ation as a baseline snapshot of the Australian female population
able 3
ummary of product exposure days and use by SLE ﬂare groups.
Product Group SLE
No ﬂare
(n = 12)
Mean ± SD 
Adhesives 8.9 ± 14.8 
Air  fresheners/deodorisers 185 ± 201 
General  cleaning 696 ± 320 
Bleach  331 ± 152 
Cleaners furniture/homewares 0.71 ± 0.71 
Cleaners carpet 1.43 ± 3.17 
Cleansing beauty 846 ± 786 
Deodorant 235 ± 118 
Dishwashing 64.3 ± 210 
Disinfectant/antiseptic 178 ± 210 
Caustic  cleaners 126 ± 197 
Dry  cleaning 71 ± 91.3  
Equipment oils & petrol 154 ± 239 
Fertilisers 74.4 ± 120 
Solid  fuels 0 
Herbicides, insecticides, pesticides 145 ± 144 
Laundry cleaners 321 ± 287 
Make-up 264 ± 167 
Paint  53.8 ± 112 
Bath  oil 0 
Powdered salt 27.3 ± 20.9 
Beauty  colorants 10.1 ± 4.23 
Perfumes 172 ± 136 
Fluoride 208 ± 67.3 
All  products 4292 ± 1402 parison of SLE participants and control group exposure days.
and their use of household and personal consumer products. In par-
ticular, the results largely showed that the use of products did not
differ between those with SLE and those without. Personal hygiene
and house/clothing cleaning were the most frequently used prod-
ucts with extension to products used for more aesthetic reasons
such as deodorizers and air fresheners. These usage patterns are
consistent with ﬁndings from other United States studies such
SLE
Flare
(n = 68)
Difference between groups
Mean ± SD p-Value
17.0 ± 47.8 0.87
124 ± 332 0.97
684 ± 269 0.14
344 ± 148 0.60
1.30 ± 5.32 0.73
1.56 ± 7.74 0.54
675 ± 329 0.24
293 ± 173 0.92
112 ± 157 0.77
150 ± 201 0.34
120 ± 163 0.46
61 ± 107 0.37
142 ± 216 0.43
74.2 ± 129 0.50
3.86 ± 31.9 0.84
187 ± 208 0.80
338 ± 267 0.57
237 ± 177 0.31
25.2 ± 47.4 0.20
1.97 ± 12.5 0.90
14.5 ± 21.4 0.03
6.95 ± 6.02 0.02
131 ± 147 0.17
258 ± 90 0.98
4287 ± 1369 0.50
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Table  4
Negative binomial regression for ﬂare days (Fc) and independent product group continuous variables (EDC) and dichotomised exposure or non-exposure with applied
cut-points.
Product groups Continuous EDC Dichotomised no
cut-point
Dichotomised 5%
cut-point
Dichotomised
10% cut-point
IRR p < 0.05 IRR p < 0.05 IRR p < 0.05 IRR p < 0.05
Adhesives 0.994 0.000 0.671 0.155 0.481 0.013 0.458 0.003
Air  fresheners/deodorisers 0.999 0.757 0.823 0.620 1.032 0.915 1.092 0.764
Cleaners general 1.001 0.807 3.608 0.000 2.324 0.069
Bleach 1.000 0.772 2.974 0.000 2.974 0.000
Cleaners furniture home wares 1.000 0.413 2.974 0.000 0.939 0.890
Cleansing beauty 0.999 0.024 0.736 0.635 1.062 0.888
Dishwashing 1.002 0.068 1.594 0.092 1.650 0.079 1.750 0.052
Disinfectants/antiseptics 0.999 0.057 1.448 0.093 0.865 0.628 0.936 0.827
Laundry cleaners 0.999 0.205 1.408 0.572 1.075 0.849 1.002 0.995
Make-up 0.998 0.002 0.946 0.891 0.857 0.653 1.034 0.915
Paint  0.991 0.000 0.807 0.517 0.742 0.270 0.680 0.161
Bath  oil 1.008 0.048 1.498 0.483 1.498 0.483 1.498 0.483
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s the “Study of use of products and exposure-related behaviors”
SUPERB) [20,21] and the “Household exposure” study of the Silent
pring Institute [22] indicating limited population differences.
Our cohort used large numbers of different products (13–81:
ean 33.1). Numerous products were used for similar purposes,
articularly in regards to household general cleaners and for insect,
est and garden weed eradication. The majority of these prod-
cts were used daily for personal care and hygienic cleaning of
ouseholds. A large number of the products contained antibacte-
ial ingredients and SLE patients nominated more products with
arketed claims aimed at reducing overall infection risks and
sed these products more frequently than similar products with-
ut antibacterial claims. Therefore, it is plausible that this practice
ay  have been adopted as a strategy to self-manage one potential
rigger for ill health.
Personal hygiene and household products are complex mix-
ures of chemicals, colorings and perfumes of both “natural” and
ynthetic origins combined to produce products with targeted
roperties of use. Formulations and concentrations of commer-
ial product ingredients change frequently,reducing the capacity
o gauge exact cause and effects of exposure, with only generalized
0
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s
Fig. 2. Non-linear non-monotonic exposure0.059 1.214 0.520 1.214 0.520
0.373 0.585 0.107 0.510 0.024
0.000 2.689 0.000 2.689 0.000
associations possible. However, some of the product groups com-
monly found in this study have been previously associated with
SLE and other autoimmune health effects. For example, Triclos an,
a common antimicrobial addition to paints and household clean-
ing products, has been found to be associated with presentation
of common SLE and thyroid illness symptoms of fatigue, headache
and skin irritation [23]. Fragrances, which can contain up to 300
different chemicals [24], have been associated with headaches, con-
tact dermatitis, and mucosal dryness, a shared symptom between
SLE and Sjögren’s [25]. Phthalate plasticizing compounds in cos-
metics, cleansers, insect repellents, fragrant perfume additives,
and food storage containers, are known respiratory irritants caus-
ing inﬂammation of the lungs and asthma exacerbation [26] and
been directly linked to SLE development [5]. In addition, there
is increasing evidence that inﬂammatory responses, as demon-
strated by allergic contact dermatitis, have been linked to chemical
components of parabens, formaldehyde and methylisothiazoli-
none added to cosmetic and cleaning products as preservatives
[27–29].
Studies exploring health effects of available products are further
hindered by the lack of consistencies and regulation in labeling
4 6
Predicted Flare Days
osure (Log Scale)
 response – adhesive product group.
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f products and the inadequacies of Material safety data sheets
MSDS) [26]. Many products do not contain completed ingredi-
nt lists and may  not be required to publicly supply MSDS for
roducts.This study did attempt to retrieve information regarding
roduct chemical ingredients based upon the product name sup-
lied in the HCPML; however, MSDS and complete ingredients and
oncentration information were not readily obtained.
.2. SRF days and association with product group use
The development and activity of hair dye use has been dis-
ussed in a number of studies [6,30,31] with conﬂicting health
mpact results. Analysis of difference between the ﬂare and non-
aring SLE subgroups in this study showed that the participants
hat reported ﬂares did not readily dye their hair and as such no
ssociation with health effects was found. It is probable that SLE
atients, particularly those experiencing active phases of their SLE
ymptomology, adhere to precautions in choosing products they
se, opting for perceived safer options and limiting exposure to
roducts previously raised as having potential adverse impacts.
lare group differences were also observed with use of cleaning
alts, speciﬁcally, ﬂaring SLE participants reported higher use of
herapeutic bath salts and simple cleaning salts of bicarbonate of
oda in preference to products with a more complex chemistry. It
s also of interest that an overall observed trend toward the use
f “natural”, “greener”, products marketed as being less toxic, (“no
asties”, “paraben free”, “petroleum free”, and “environmentally
riendly”) was found within the HCPML brand names supplied by
ll participants. However, the reason for purchase and use of such
roducts was not explored and warrants further investigation. It of
nterest that both Dodson et al. [26] and Steinemann et al. [32] did
ot ﬁnd signiﬁcant differences in chemical ingredient analysis of
healthier choice products’, with many containing chemicals com-
onents of fragrance, preservatives, and parabens despite market
abelling to the contrary.
Signiﬁcant effects were found in univariate analysis in relation
o the length of diagnosis time and also for use of ITM during the
tudy year. As reported in Squance et al. [33] participants’ use of ITM
as common (82.5%) with multiple ITM’s being prescribed, consis-
ent withselection bias for those with more severe SLE requiring
TM for disease management.
Regression models found mixed protective and increased SRF
ay risk associations on continuous product EDC data. An increased
RF day risk (IRR 1.008) was indicated in participants that rou-
inely used bath mineral oils. The HCPML named brand of bath
il ingredients were crosschecked and all contained hydrocarbon
etrochemicals, fragrances, as well as parabens which have been
ssociated with adverse SLE health impacts. In addition, mineral
ils commonly contain pristane which has been linked to renal dis-
ase and autoanti body production inducing a lupus-like syndrome
n mice [34,35]. Overall 37 (46.3%) of SLE participants had a renal
isorder in the form of persistent proteinuria or cellular cast pre-
entation documented within their health record, and 73 (91.3%)
ad a positive result for auto antibody presence as part of their
ymptom spectrum. However, the retrospective study nature did
ot have the capacity to match individual participant SRF to times
f product use, and so correlation to renal dysfunction events or
hanges in auto antibodies could not be drawn.
As indicated by relative risk values, inverse associations
etween products and SRF days were found in this study for
ersonal cleansing products (IRR 0.999) and also for participant
xposure to make up group (foundation make-up and sunscreen,
MSS) (IRR 0.998). A calculated reduction of SRF days by 0.15% was
ound for each day of FMSS product use and was not found to be
ontingent on ITM use; however, no assessment of SLE or SRF sever-
ty was made [33]. It is suggested that this protective effect couldeports 2 (2015) 880–888
be directly related to the reduction of UV exposure, a known ﬂare
trigger. The study by Vila et al. [36] found signiﬁcantly lower renal
involvement, thrombocytopenia, hospitalisations, and a reduction
in ITM use in patients that adopted regular UV protection strategies
inclusive of sunscreen use. UV protective chemicals and mineral
based pigments are a common manufacturing addition in many
household and personal products [37–39]. Thisresults in almost
ubiquitous population exposure as a result of daily activities. This is
highlighted by raised urinary levels of the UV protective chemical,
benzophenone-3, in a large general population study (NHANES) in
the US with 96.8% of samples containing the chemical [40]. Despite
this ﬁnding, it is important to understand that presence of a chem-
ical in human tissue as well as urine or blood does not necessarily
mean that adverse health effects will or have occurred.
In this study, a number of paradoxical protective effects were
found for estimates of exposure to adhesives (IRR 0.994, CI
0.991–0.997) as well as paint (IRR 0.99, CI 0.986–0.995). These prod-
uct groups contain shared chemical components of solvents and
epoxy resins, aromatic amines and hydrocarbon structures which
have been linked with increased risk in the development of SLE,
lupus-like illnesses as well as other autoimmune illnesses [6,31,41].
It is thought that the aromatic amine, hydrazine and hydrocarbon
structures contained in over 70 pharmaceutical drugs (e.g., cloni-
dine, ibuprofen, penicillamine, tetracyclines) as well as commercial
product mixtures of paints, dyes and adhesives can be a catalyst to
the development and exacerbation of symptoms of drug induced
lupus [6]. In light of the evidence supporting increased risk, our
ﬁndings were surprising and are difﬁcult to explain.This study’s
inventory of products used self-reported measures of frequency
of use allowing generalized semi-quantiﬁcation of exposure. This,
along with the retrospective nature without ﬁrm measures of
timing, duration of use and consistency of exposure, may  have con-
tributed to either under or over estimation of exposure. It is also
probable that over-estimation of exposure days in relation to out
gassing and allocation of exposure for less toxic hobby adhesive
and paint products may have caused misclassiﬁcation bias.It is also
possible that dose response associations for adhesives and paint
display non-linear non-monotonic characteristics. These types of
relationships are common in toxicology [42] , with reports that
associations can display a phenomenon where low dose exposure
may demonstrate paradoxically beneﬁcial or protective effects, and
higher doses displaying increased risk [43,44]. This phenomenon is
often described as “hormesis” and still remains a much-discussed
concept.
This study’s paradoxical results and the appearance of non-
linear non-monotonic dose-response relationships in plotted
product group and SRF out come data prompted the use of mul-
tivariate models using dichotomous data. This method is applied in
clinical research and exposure risk assessments when: exposures
are small; incomplete concentrations of chemical components and
safe exposure limits are available; or when differing environments
are to be evaluated [15,45,46]. Whilst dichotomising continuous
data is considered suboptimal with the tendency to lose statistical
power of association and an increased risk of false positive results
[47], it can offer insight into simple risk interpretation of data elim-
inating the need for linearity assumptions [48]. Dichotomised data
for these variables did not support a protective effect indicating
that these results represent type 1 error, i.e., false positives.
On the other hand, dichotomised outcomes did yield consider-
able increased SRF relative risk values for some product groups:
general cleaners (IRR = 3.6), bleach (IRR = 2.9), specialist furniture
and home appliance cleaners (IRR=2.9). All of these product groups
are complex mixtures with solvent surfactants, fragrances, preser-
vatives including parabens and formaldehyde, phthalates, and
antibacterial additives which have reported adverse health impacts
relevant to SLE patients.
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The dichotomised model analysis also identiﬁed ﬂuoride,
resent in ﬂuoridated potable public water supplies, as a potential
roduct which may  increase the risk of SRF. However, inter-
retation of this result should be treated with caution due to
lmost universal exposure in participants and applied cut-point
evels being too narrow.Thirty nine percent of SLE participants did
eport using ﬂuoridated water for washing purposes only; how-
ver, despite choosing to limit purpose of use and therefore overall
xposure, daily exposure would have still occurred in all but one
articipant.
Fluoride is a common additive in many oral hygiene products
or dental caries prevention [49] which is particularly important in
LE patients with dryness symptoms or co-existing Sjögren’s syn-
rome. Reported adverse health effects of high levels of ﬂuoride
xposure have included skeletal ﬂuorosis (brittle bones), joint pain
nd limitations to joint movements [4,50]. Drinking ﬂuoridated
ater wasalso found to be nephrotoxic in animals with chronic
idney disease and impaired renal excretion [51] , and reported to
xacerbate SLE by disrupting the synthesis of collagen leading to
reakdown in the skin, muscle, ligaments, bone, lungs and kidneys
52]. In view of these reported health effects and the high represen-
ation of joint/muscular pains and renal involvement in SLE patients
14,53], ﬂuoride exposure remains of investigative interest.
.3. Study strengths and weaknesses
Whilst a case/control approach is suitable for studying retro-
pective multiple exposures particularly in rare illness [54], the
tudy had some limitations. The basis of data collection was  from
he participants lived experience and provides retrospective self-
eported data of a small relatively homogeneous female Australian
opulation. This would be subject to recall bias. In addition, SRF
as not able to be conﬁrmed by review of clinical notes as the
tudy was undertaken outside of clinical appointments with partic-
pants being recruited from multiple centers. Therefore SRF was  not
rosschecked against standard disease activity measures. To reduce
ias, a single researcher used a standardized method incorporating
 strict structured interview technique [14] with a clearly deﬁned
escription of a ﬂare event [13]. This technique may have resulted
n an overestimation of SRF however it would be expected that any
ias would be toward the null. The results should be viewed as
fa pilot nature with the need for: (i) a comprehensive prospective
tudy protocol documenting speciﬁc product use over time; and (ii)
ssessment of disease activity with validated tools.
. Conclusion
There is growing evidence that a wide array of these chemical
omponents can produce SLE-like diseases;however, the interac-
ion of environmental exposures and adverse health consequences
or SLE, particularly their association with exacerbation of pre-
xisting SLE symptoms ‘ﬂares’, is poorly understood.
We found that patterns of use did not signiﬁcantly differ
etween case/control groups, with the exception that SLE partici-
ants had a tendency to opt for products that were marketed as ‘less
oxic’ than others. Regression analyses indicated that there may  be
 protective element to use of personal cleaning and make-up prod-
cts and an increased risk of ﬂares with exposure to bath oils. The
esults also showed paradoxical effects of reduced risk associated
ith exposure to adhesives and paint which could not be readily
xplained but could be due to inﬂated type 1 error due to multi-
le comparisons. There was also some support for an increased risk
f ﬂares with general cleaners, bleach, and specialist furniture and
ome appliance cleaners but these remain to be independently ver-
ﬁed. The reported environmental associations found in this study
[eports 2 (2015) 880–888 887
offer the possibility of life-style interventions to reduce autoim-
mune symptom exacerbation.
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